English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The research in telemedicine has been evolving for several years, nevertheless, there isn’t a clear designation of which hardware and/or software tools should those who intend to research on this topic use. Given this situation, the objective of this study is to review and established the most used electronic cards and microcontrollers in vital signs remote monitoring systems for specific chronic patients. Also, this research intended to identify which are the motivations, challenges and recommendations to serve this study as support for further research in this area. To accomplish the above, four databases: ScienceDirect, PubMed, Science AAAS and IEEE Xplore, as well as the search engine Google Scholar academic referents, were used for developed literature review. Likewise, among 330 abstracts were searched to determine their relevance and affinity regarding the targeted scope. At the end, 35 documents were selected due to their high level of importance. According to the information extracted from such scientific papers, Arduino ONE electronic development platform has been the most used (considering low-end embedded devices) for the creation of this type of systems since 2016. Further into the review, the followed process and conclusions will be detailed and further explored.

ieee access

Systematic Review of Platforms Used for Remote Monitoring of Vital Signs in Patients With Hypertension, Asthma and/or Chronic Obstructive Pulmonary Disease